Logo image of TRAW

TRAWS PHARMA INC (TRAW) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TRAW - US68232V8845 - Common Stock

1.58 USD
+0.31 (+24.41%)
Last: 1/13/2026, 3:28:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
TRAW revenue by date.TRAW revenue by date.
226K226K226K2.856M
1,163.72%

-100.00%
26.724M
EBITDA
YoY % growth
TRAW ebitda by date.TRAW ebitda by date.
-19.613M
-19.00%
-19.98M
-1.87%
-24.99M
-25.08%
-29.172M
-16.73%
-33.864M
-16.08%
N/A
EBIT
YoY % growth
TRAW ebit by date.TRAW ebit by date.
-19.627M
-18.98%
-20M
-1.90%
-25M
-25.00%
-27.948M
-11.79%
-41.106M
-47.08%
-39.882M
2.98%
Operating Margin
TRAW operating margin by date.TRAW operating margin by date.
-8,684.51%-8,849.56%-11,061.95%-978.57%N/A-149.24%
EPS
YoY % growth
TRAW eps by date.TRAW eps by date.
-22.75
3.19%
-22.50
1.10%
N/A
-599.72%
-0.04
99.97%
-2.35
-5,650.00%
-1.32
43.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.95
-102.04%
-0.94
88.56%
-0.55
93.83%
-0.51
94.54%
-0.57
70.68%
Revenue
Q2Q % growth

-100.00%

-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-17.238M
-226.48%
-10.2M
-96.15%
-10.2M
-716.00%
-10.302M
-153.74%
-10.506M
39.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-3,400.00%
-8.93%
Q1 2025
Q2Q % growth

-3,395.65%
-8.20%
Q4 2024
Q2Q % growth
95.66
2,113.89%
-9.74105.401,082.03%
Q3 2024
Q2Q % growth
-8.81
-53.22%
-6.25-2.56-41.02%
Q2 2024
Q2Q % growth

94.90%
-0.26%
Q1 2024
Q2Q % growth

96.65%
-0.23%
Q4 2023
Q2Q % growth
-4.75
26.92%
-6.461.7126.47%
Q3 2023
Q2Q % growth
-5.75
11.54%
-7.401.6522.24%
Q2 2023
Q2Q % growth
-5.00
-5.26%
-7.972.9737.25%
Q1 2023
Q2Q % growth
-7.00
-40.00%
-7.590.597.73%
Q4 2022
Q2Q % growth
-6.50
-73.33%
-7.140.648.96%
Q3 2022
Q2Q % growth
-6.50
-18.18%
-5.42-1.08-19.95%
Q2 2022
Q2Q % growth
-4.75
29.63%
-5.040.295.68%
Q1 2022
Q2Q % growth
-5.00
33.33%
-4.85-0.16-3.20%
Q4 2021
Q2Q % growth
-3.75
66.67%
-6.893.1445.53%
Q3 2021
Q2Q % growth
-5.50
51.11%
-8.332.8333.97%
Q2 2021
Q2Q % growth
-6.75
55.00%
-7.270.527.12%
Q1 2021
Q2Q % growth
-7.50
33.33%
-11.483.9734.64%
Q4 2020
Q2Q % growth
-11.25 -13.392.1415.97%
Q3 2020
Q2Q % growth
-11.25 -12.751.5011.76%
Q2 2020
Q2Q % growth
-15.00 -11.48-3.53-30.72%
Q1 2020
Q2Q % growth
-11.25 -21.049.7946.52%
TRAW Yearly EPS VS EstimatesTRAW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -20K -40K -60K -80K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
2.733M
4,694.74%
61.2K2.672M4,365.69%
Q1 2025
Q2Q % growth
57K
1.79%
61.2K-4.2K-6.86%
Q4 2024
Q2Q % growth
60K
7.14%
61.2K-1.2K-1.96%
Q3 2024
Q2Q % growth
57K 59.16K-2.16K-3.65%
Q2 2024
Q2Q % growth
57K 61.2K-4.2K-6.86%
Q1 2024
Q2Q % growth
56K
-38.31%
61.2K-5.2K-8.50%
Q4 2023
Q2Q % growth
56K
-5.34%
66.637K-10.637K-15.96%
Q3 2023
Q2Q % growth
57K
-3.23%
70.635K-13.635K-19.30%
Q2 2023
Q2Q % growth
57K
-2.39%
70.635K-13.635K-19.30%
Q1 2023
Q2Q % growth

4.30%
90.78K%
Q4 2022
Q2Q % growth

-2.52%
59.16K%
Q3 2022
Q2Q % growth

8.29%
58.905K%
Q2 2022
Q2Q % growth

186.25%
58.395K%
Q1 2022
Q2Q % growth

42.22%
87.037K%
Q4 2021
Q2Q % growth

48.75%
60.69K%
Q3 2021
Q2Q % growth

-96.17%
54.397K%
Q2 2021
Q2Q % growth

-88.44%
20.4K%
Q1 2021
Q2Q % growth

-61.04%
61.2K%
TRAW Yearly Revenue VS EstimatesTRAW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 5M 10M 15M 20M 25M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 80.02% 99.89% 99.89%
RevenueN/A -100% 1117.39% 1117.39%